Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria : a prospective cohort study

Tools
- Tools
+ Tools

Avong, Yohanna Kambai, Jatau, Bolajoko, Gurumnaan, Ritmwa, Danat, Nanfwang, Okuma, James, Usman, Istifanus, Mordi, Dennis, Ukpabi, Blessing, Kayode, Gbenga Ayodele, Dutt, Saswata et al.
(2018) Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria : a prospective cohort study. PLoS One, 13 (8). e0200810. doi:10.1371/journal.pone.0200810

[img]
Preview
PDF
WRAP-addressing-under-reporting-adverse-Uthman-2018.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (597Kb) | Preview
[img] PDF
wms_popevtech_hsci-290818-wrap--plos_one_accepted20version.pdf - Accepted Version
Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer.

Download (193Kb)
Official URL: https://doi.org/10.1371/journal.pone.0200810

Request Changes to record.

Abstract

Background
Adverse Drug Reactions (ADRs) are a major clinical and public health problem world-wide. The prompt reporting of suspected ADRs to regulatory authorities to activate drug safety surveillance and regulation appears to be the most pragmatic measure for addressing the problem. This paper evaluated a pharmacovigilance (PV) training model that was designed to improve the reporting of ADRs in public health programs treating the Human Immunodeficiency Virus (HIV), Tuberculosis (TB) and Malaria.

Methods
A Structured Pharmacovigilance and Training Initiative (SPHAR-TI) model based on the World Health Organization accredited Structured Operational Research and Training Initiative (SOR-IT) model was designed and implemented over a period of 12 months. A prospective cohort design was deployed to evaluate the outcomes of the model. The primary outcomes were knowledge gained and Individual Case Safety Reports (ICSR) (completed adverse drug reactions monitoring forms) submitted, while the secondary outcomes were facility based Pharmacovigilance Committees activated and health facility healthcare workers trained by the participants.

Results
Fifty-five (98%) participants were trained and followed up for 12 months. More than three quarter of the participants have never received training on pharmacovigilance prior to the course. Yet, a significant gain in knowledge was observed after the participants completed a comprehensive training for six days. In only seven months, 3000 ICSRs (with 100% completeness) were submitted, 2,937 facility based healthcare workers trained and 46 Pharmacovigilance Committees activated by the participants. Overall, a 273% increase in ICSRs submission to the National Agency for Food and Drug Administration and Control (NAFDAC) was observed.

Conclusion
Participants gained knowledge, which tended to increase the reporting of ADRs. The SPHAR-TI model could be an option for strengthening the continuous reporting of ADRs in public health programs in resource limited settings.

Item Type: Journal Article
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Medicine > Warwick Medical School > Health Sciences > Population, Evidence & Technologies (PET)
Faculty of Medicine > Warwick Medical School
SWORD Depositor: Library Publications Router
Library of Congress Subject Headings (LCSH): Drugs -- Side effects, Drug monitoring, Pharmacovigilance, HIV (Viruses), Tuberculosis, Malaria
Journal or Publication Title: PLoS One
Publisher: Public Library of Science
ISSN: 1932-6203
Official Date: 22 August 2018
Dates:
DateEvent
22 August 2018Published
3 July 2018Accepted
Volume: 13
Number: 8
Article Number: e0200810
DOI: 10.1371/journal.pone.0200810
Status: Peer Reviewed
Publication Status: Published
Publisher Statement: ** From PLOS via Jisc Publications Router. ** History: received 21-09-2017; collection 2018; accepted 03-07-2018; epub 22-08-2018. ** Licence for this article: http://creativecommons.org/licenses/by/4.0/
Access rights to Published version: Open Access
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
Special Programme for Research and Training in Tropical DiseasesUNICEFhttp://dx.doi.org/10.13039/100006641
Special Programme for Research and Training in Tropical DiseasesUnited Nations Development Programme‏http://viaf.org/viaf/131378718
UNSPECIFIEDWorld Bank Grouphttp://dx.doi.org/10.13039/100004421
B40396World Health Organizationhttp://dx.doi.org/10.13039/100004423
Related URLs:
  • http://creativecommons.org/licenses/by/4...
Contributors:
ContributionNameContributor ID
UNSPECIFIEDFigueras, AlbertUNSPECIFIED

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us